Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as “one-dose-fits-all strategy” remains...
Background: Several approaches have been proposed for risk-stratification and primary prevention of ...
Background: It is unknown whether population based single assessment of cardiovascular disease (CVD)...
Cardiovascular disease (CVD) is a major cause of death among patients with diabetes. Antiplatelet th...
Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substanti...
The Joint European Societies (JES) guidelines on cardiovascular disease (CVD) prevention published i...
The need for aspirin therapy as part of primary prevention of cardiovascular (CV) disease is current...
In recent years there is a positive trend in the development of preventive medicine, in particular, ...
Cardiovascular disease (CVD) is the single most common cause of death around the world, with an incr...
Cardiovascular (CV) disease (CVD) is still a major cause of morbidity and mortality in many countrie...
Almost everyone has heard the saying, “One size does not fit all.” This adage is especially true in...
European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V ...
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the populatio...
Background:European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUR...
BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EU...
Aims: Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to pa...
Background: Several approaches have been proposed for risk-stratification and primary prevention of ...
Background: It is unknown whether population based single assessment of cardiovascular disease (CVD)...
Cardiovascular disease (CVD) is a major cause of death among patients with diabetes. Antiplatelet th...
Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substanti...
The Joint European Societies (JES) guidelines on cardiovascular disease (CVD) prevention published i...
The need for aspirin therapy as part of primary prevention of cardiovascular (CV) disease is current...
In recent years there is a positive trend in the development of preventive medicine, in particular, ...
Cardiovascular disease (CVD) is the single most common cause of death around the world, with an incr...
Cardiovascular (CV) disease (CVD) is still a major cause of morbidity and mortality in many countrie...
Almost everyone has heard the saying, “One size does not fit all.” This adage is especially true in...
European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V ...
Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the populatio...
Background:European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUR...
BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EU...
Aims: Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to pa...
Background: Several approaches have been proposed for risk-stratification and primary prevention of ...
Background: It is unknown whether population based single assessment of cardiovascular disease (CVD)...
Cardiovascular disease (CVD) is a major cause of death among patients with diabetes. Antiplatelet th...